Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CX3CL1/Fractalkine Chemokine Domain Mouse anti-Human, Clone: 81513, R&D Systems™

Mouse Monoclonal Antibody

Specifications

Antigen CX3CL1/Fractalkine
Immunogen NS0 and E. coli-derived recombinant human CX3CL1/Fractalkine Chemokine Domain Gln25-Arg339 (Ser199Asn) Accession # P78423
Clone 81513
Applications Western Blot, Immunohistochemistry
Conjugate Unconjugated
View More Specs

Products 3
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
MAB3651SP
View Documents
R&D Systems
MAB3651SP
25 ug N/A
MAB3651100
View Documents
R&D Systems
MAB3651100
100 ug N/A
MAB3651500
View Documents
R&D Systems
MAB3651500
500 ug N/A
Description

Description

CX3CL1/Fractalkine Chemokine Domain Monoclonal antibody MAB3651 Specifically detects CX3CL1/Fractalkine Chemokine Domain in Human samples. It is validated for Immunohistochemistry, Western Blotting
Specifications

Specifications

CX3CL1/Fractalkine
81513
Unconjugated
P78423
Monoclonal
Primary
Detects human CX3CL1/Fractalkine Chemokine Domain in direct ELISAs and Western blots.
Protein A or G purified from hybridoma culture supernatant
NS0 and E. coli-derived recombinant human CX3CL1/Fractalkine Chemokine Domain Gln25-Arg339 (Ser199Asn) Accession # P78423
Western Blot, Immunohistochemistry
Purified
Mouse
IgG1
6376
RUO
SDS
Product Certifications

For Research Use Only

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit